Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 9 (2011): Issue 5 (May 2011)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Citation Alert
Erratum
Pages: xxx
NCCN News
Pages: xxxvii–xlii
Oncology Research Program
Pages: xlv–xlviii
Texting the Doctor
By:
Harold J. Burstein
Pages: 459
Pathways: A Road to Restriction?
By:
William T. McGivney
Pages: 462–463
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy
By:
Bhumsuk Keam
,
Jeong-Hoon Lee
,
Seock-Ah Im
and
Jung-Hwan Yoon
Pages: 465–477
Non-Hodgkin's Lymphomas
By:
Andrew D. Zelenetz
,
Jeremy S. Abramson
,
Ranjana H. Advani
,
C. Babis Andreadis
,
Nancy Bartlett
,
Naresh Bellam
,
John C. Byrd
,
Myron S. Czuczman
,
Luis E. Fayad
,
Martha J. Glenn
,
Jon P. Gockerman
,
Leo I. Gordon
,
Nancy Lee Harris
,
Richard T. Hoppe
,
Steven M. Horwitz
,
Christopher R. Kelsey
,
Youn H. Kim
,
Ann S. LaCasce
,
Auayporn Nademanee
,
Pierluigi Porcu
,
Oliver Press
,
Barbara Pro
,
Nashitha Reddy
,
Lubomir Sokol
,
Lode J. Swinnen
,
Christina Tsien
,
Julie M. Vose
,
William G. Wierda
,
Joachim Yahalom
and
Nadeem Zafar
Pages: 484–560
Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance
By:
Rupali Roy
and
Leo I. Gordon
Pages: 563–571
Role of Routine Imaging in Lymphoma
By:
Nina D. Wagner-Johnston
and
Nancy L. Bartlett
Pages: 575–584
Collapse
Expand
Search
Issue
Journal
[18.204.2.190]
18.204.2.190
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
